Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianyao Migu Tablets in Elderly Osteoporotic Low Back Pain (Phase II)
CTR20220215Phase 2Completed
- Sponsor
- Shanghai Hutchison Pharmaceuticals Ltd.
- Start
- Feb 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jianyao Migu in osteoporosis, lumbodynia (LBP), sponsored by Shanghai Hutchison Pharmaceuticals Ltd.. Started Feb 2022; status: completed.
02
Drugs
Jianyao Migu
03
Conditions
osteoporosislumbodynia (LBP)
Beyond the preview
Go deeper on CTR20220215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220215.